RB forecasts 2% sales drop after cyber attack

Nurofen: owner RB was hit by last week's global cyber attack
Nurofen: owner RB was hit by last week's global cyber attack

RB, the owner of Nurofen and Durex, has warned that last week's cyber attack will lead to a drop in a 2% drop in sales for the second quarter of the year.

It has been reported that this drop in sales is equivalent to approximately £100m. However the business added that it will be able to make up some of the revenue in the third quarter.

RB expects like for like growth for the full year to be up 2%, down from a previously projected 3%.

The effects of last week’s global attack, which also hit WPP, have still not been fully resolved but RB said that the problem has been "materially contained".

In a statement, it said: "The attack did disrupt the company’s ability to manufacture and distribute products to customers in multiple markets across the RB Group.

"Consequently, we were unable to ship and invoice some orders to customers prior to the close of the quarter. Some of our factories are currently still not operating normally but plans are in place to return to full operation."


Start Your Free 30-Day Free Trial

Get the very latest news and insight from Campaign with unrestricted access to campaignlive.com , plus get exclusive discounts to Campaign events.

Become a subscriber


Don’t miss your daily fix of breaking news, latest work, advice and commentary.

register free